Etaracizumab (original) (raw)
إيتاراسيزوماب هو جسم مضاد وحيد النسيلة مأنسن يستخدم في علاج الأورام الميلانينية النقيلة وسرطان الموثة وسرطان المبيض وأنواع أخرى من السرطان. تصنعه .
| Property | Value |
|---|---|
| dbo:abstract | إيتاراسيزوماب هو جسم مضاد وحيد النسيلة مأنسن يستخدم في علاج الأورام الميلانينية النقيلة وسرطان الموثة وسرطان المبيض وأنواع أخرى من السرطان. تصنعه . (ar) Etaracizumab, also known as MEDI-522, trade name Abegrin, is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune. It is an enhanced iteration of Vitaxin, also known as MEDI-523. Both are derived from the mouse antibody LM609. (en) L'etaracizumab o etaratuzumab o MEDI-522, nome commerciale Abegrin, è un anticorpo monoclonale umanizzato, studiato per il trattamento del melanoma metastatico e del carcinoma della prostata, del tumore dell'ovaio ed altri tipi di tumore. Il farmaco è sviluppato dalla . Il target molecolare del farmaco è l'antigene: integrina alfa-v beta-3. (it) |
| dbo:alternativeName | Abegrin (en) |
| dbo:casNumber | 892553-42-3 |
| dbo:fdaUniiCode | 41W9MFI160 |
| dbo:kegg | D09342 |
| dbo:wikiPageID | 12233187 (xsd:integer) |
| dbo:wikiPageLength | 3524 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1050073723 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:MedImmune dbr:Melanoma dbr:Prostate_cancer dbr:Alpha-v_beta-3 dbc:AstraZeneca_brands dbc:Monoclonal_antibodies_for_tumors dbr:Vitaxin dbr:Humanized_monoclonal_antibody dbr:Ovarian_cancer dbr:Metastatic |
| dbp:atcPrefix | none (en) |
| dbp:c | 6392 (xsd:integer) |
| dbp:casNumber | 892553 (xsd:integer) |
| dbp:chemspiderid | none (en) |
| dbp:h | 9908 (xsd:integer) |
| dbp:kegg | D09342 (en) |
| dbp:mabType | mab (en) |
| dbp:n | 1732 (xsd:integer) |
| dbp:o | 1996 (xsd:integer) |
| dbp:s | 42 (xsd:integer) |
| dbp:source | zu/o (en) |
| dbp:target | alpha-v beta-3 integrin (en) |
| dbp:tradename | Abegrin (en) |
| dbp:type | mab (en) |
| dbp:unii | 41 (xsd:integer) |
| dbp:verifiedfields | changed (en) |
| dbp:verifiedrevid | 457121095 (xsd:integer) |
| dbp:watchedfields | changed (en) |
| dbp:wikiPageUsesTemplate | dbt:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Keggcite dbt:Monoclonal-antibody-stub dbt:Monoclonals_for_tumors |
| dcterms:subject | dbc:AstraZeneca_brands dbc:Monoclonal_antibodies_for_tumors |
| gold:hypernym | dbr:Antibody |
| rdf:type | owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:WikicatMonoclonalAntibodiesForTumors yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459 umbel-rc:DrugProduct |
| rdfs:comment | إيتاراسيزوماب هو جسم مضاد وحيد النسيلة مأنسن يستخدم في علاج الأورام الميلانينية النقيلة وسرطان الموثة وسرطان المبيض وأنواع أخرى من السرطان. تصنعه . (ar) Etaracizumab, also known as MEDI-522, trade name Abegrin, is a humanized monoclonal antibody which is being investigated for the treatment of metastatic melanoma, prostate cancer, ovarian cancer and various other types of cancer. It is manufactured by MedImmune. It is an enhanced iteration of Vitaxin, also known as MEDI-523. Both are derived from the mouse antibody LM609. (en) L'etaracizumab o etaratuzumab o MEDI-522, nome commerciale Abegrin, è un anticorpo monoclonale umanizzato, studiato per il trattamento del melanoma metastatico e del carcinoma della prostata, del tumore dell'ovaio ed altri tipi di tumore. Il farmaco è sviluppato dalla . Il target molecolare del farmaco è l'antigene: integrina alfa-v beta-3. (it) |
| rdfs:label | إيتاراسيزوماب (ar) Etaracizumab (en) Etaracizumab (it) |
| owl:sameAs | freebase:Etaracizumab yago-res:Etaracizumab wikidata:Etaracizumab dbpedia-ar:Etaracizumab dbpedia-it:Etaracizumab https://global.dbpedia.org/id/3SjyF |
| prov:wasDerivedFrom | wikipedia-en:Etaracizumab?oldid=1050073723&ns=0 |
| foaf:isPrimaryTopicOf | wikipedia-en:Etaracizumab |
| is dbo:wikiPageRedirects of | dbr:Etaratuzumab |
| is dbo:wikiPageWikiLink of | dbr:Alpha-v_beta-3 dbr:List_of_therapeutic_monoclonal_antibodies dbr:Vitaxin dbr:List_of_drugs:_A–Ab dbr:List_of_drugs:_Et dbr:Etaratuzumab |
| is foaf:primaryTopic of | wikipedia-en:Etaracizumab |